NCT00414180View on ClinicalTrials.gov

Bupropion SR for Treating Smokeless Tobacco Use

PHASE3CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Smokeless Tobacco
Interventions
DRUG

Bupropion SR

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

West Virginia University

OTHER

lead

Mayo Clinic

OTHER

NCT00414180 - Bupropion SR for Treating Smokeless Tobacco Use | Biotech Hunter | Biotech Hunter